GlassScriptPhysician profile
Viresh Patel
NPI 1932425196
$9,740.08
in general payments reported to CMS, 2019-2025
38 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,657 · 2020: $1,416 · 2021: $1,765 · 2022: $1,151 · 2023: $1,355 · 2024: $1,313 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,751.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,076.68 | 2019-2025 | Ozempic, Rybelsus, Tresiba |
| Astrazeneca Pharmaceuticals LP | $2,061.02 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $693.31 | 2021-2025 | |
| Lilly USA, LLC | $668.48 | 2019-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $639.66 | 2019-2024 | |
| Glaxosmithkline, LLC. | $597.48 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $453.81 | 2020-2025 | Jardiance |
| Qiagen, LLC | $359.63 | 2019 | |
| Pfizer INC. | $344.25 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $331.29 | 2021-2025 | |
| Abbott Laboratories | $140.66 | 2024-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $140.18 | 2019-2021 | |
| Amarin Pharma, INC. | $135.64 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.35 | 2024 | Xifaxan |
| Inspire Medical Systems, INC. | $112.03 | 2023-2025 | Inspire |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viresh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.